Sanofi H1 2020 business EPS(1) growth of 9.2%(2) driven by transformation
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Qatar Investment Authority targets $20B partnership with JPMorgan - Bloomberg
Sanofi (SNY) Tops Q2 EPS by EUR0.07
July 29, 2020 6:51 AM EDTSanofi (NASDAQ: SNY) reported Q2 EPS of EUR1.28, EUR0.07 better than the analyst estimate of EUR1.21. Revenue for the quarter came in at EUR8.21 billion versus the consensus estimate of EUR8.39 billion.
Full-year 2020 business EPS(1) guidance revised upward:
Sanofi now... More
